The contribution of keratinocytes to the pathogenesis of atopic dermatitis

European Journal of Dermatology

Volumn 16, Issue 2, 2006, Pages 125-131

  Pastore, Saveria ^a   Mascia, Francesca ^a   Girolomoni, Giampiero ^b  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Atopic dermatitis; Chemokines; Cytokines; Epidermal differentiation; Epithelial cells; Keratinocytes; Serine proteinases

Indexed keywords

CERAMIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 4; RANTES; SERINE PROTEINASE; TRANSCRIPTION FACTOR;

ATOPIC DERMATITIS; BIOCHEMISTRY; CELL SURVIVAL; CORNEODESMOSOME; DENDRITIC CELL; DESMOSOME; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE EXPRESSION REGULATION; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; KERATINOCYTE; MEDIATOR RELEASE; REVIEW; SYSTEMATIC REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

CYTOKINES; DERMATITIS, ATOPIC; HUMANS; KERATINOCYTES;

EID: 33645581525     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Girolomoni G, Pastore S. Epithelial cells and atopic diseases. Curr Allergy Asthma Rep 2001; 1: 481-2.
2. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wüthrich B. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001; 56: 841-9.
3. Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermatitis 1999; 10: 119-26.
4. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005; 125: 183-200.
5. Klunker S, Trautmann A, Akdis M, Verhagen J, Schmid-Grendelmeyer P, Blaser K, et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis relase IFN-γ-inducible protein 10, monokine induced by IFN-γ, and IFN-γ-inducible α- chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J Immunol 2003; 171: 1078-84.
6. Pastore S, Mascia F, Mariotti F, Dattilo C, Girolomoni G. Chemokine networks in inflammatory skin diseases. Eur J Dermatol 2004; 14: 203-8.
7. Pastore S, Cavani A, Albanesi C, Girolomoni G. Chemokines of human skin, in: Bos JD, ed. Skin Immune System. 3rd ed. Boca Raton: CRC Press, 2005: 373-92; (CA).
8. Trautmann A, Altznauer F, Akdis M, Simon HU, Disch R, Brocker EB, et al. The differential fate of cadherins during T cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol 2001; 117: 927-34.
9. Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004; 114: 1176-82.
10. Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G. Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005; 4: 329-34.
11. Hatano Y, Terashi H, Arakawa S, Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by TNF-α and IFN-γ in human epidermis. J Invest Dermatol 2005; 124: 786-92.
12. Girolomoni G, Sebastiani S, Albanesi C, Cavani A. T-cell sub-populations in the development of atopic and contact allergy. Curr Opin Immunol 2001; 13: 733-7.
13. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New Insights into atopic dermatitis. J Clin Invest 2004; 113: 651-7.
14. Sicherer SH, Leung DYM. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects. J Allergy Clin Immunol 2005; 116: 153-63.
15. Zheng X, Nakamura K, Tojo M, Akiba H, Oyama N, Nishibu A, et al. Ultraviolet A irradiation inhibits thymus and activation-regulated chemokine (TARC/CCL17) production by a human keratinocyte HaCaT cell line. Eur J Dermatol 2003; 13: 348-53.
16. Giustizieri ML, Mascia F, Frezzolini A, De Pità O, Chinni ML, Giannetti A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a different chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001; 107: 871-7.
17. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S. Enhanced production or CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001; 293: 350-5.
18. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-65.
19. Nomura I, Boguniewicz GB, Darst MA, Travers JB, Leung DYM. Distinct patterns or gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003; 112: 1195-202.
20. Gunther C, Bello-Fernandez C, Kopp T, Kund J, Carbadillo-Perrig N, Hinteregger S, et al. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 2005; 174: 1723-8.
21. Pivarcsi A, Gompert M, Dieu-Nosjean MC, Lauerma A, Kubitza R, Meller S, et al. CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J Immunol 2004; 173: 5810-7.
22. Schmuth M, Neyer S, Rainer C, Grassegger A, Fritsch P, Romani N, Heufler C. Expression of the C-C chemokine MIP-3α/CCL20 in human epidermis with impaired permeability barrier function. Exp Dermatol 2002; 11: 135-42.
23. Reich K, Hugo S, Middel P, Blaschke V, Heine A, Gutgesell C, et al. Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis. J Allergy Clin Immunol 2002; 109: 681-7.
24. Reich K, Heine H, Hugo S, Blaschke V, Middel P, Kaser A, et al. Engagement of the FceRI stimulates the production of IL-16 in atopic dermatitis. J Immunol 2001; 167: 6321-9.
25. Vulcano M, Albanesi C, Stopacciaro A, Bagnati R, D'Amico G, Struyf S, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001; 31: 812-22.
26. D'Ambrosio D, Albanesi C, Lang R, Girolomoni G, Sinigaglia F, Laudanna C. Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol 2002; 169: 2303-12.
27. Hijnen D, Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and ClACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004; 113: 334-40.
28. Gompert M, Dieu-Nosjean MC, Winterberg F, Bünemann E, Kubitza RC, Da Cunha L, et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 2005; 174: 5082-91.
29. Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S. Expression of fraktalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol 2004; 113: 940-8.
30. Jost M, Kari C, Rodeck U. The EGF receptor - an essential regulator of multiple epidermal functions. Eur J Dermatol 2000; 10: 505-10.
31. Hamilton LM, Torres-Lozano C, Puddicombe SM, Richter A, Kimber I, Dearman RJ, et al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy 2003; 33: 233-40.
32. Lukacs NW, Miller AL, Hogaboam CM. Chemokine receptors in asthma: searching for the correct immune targets. J Immunol 2003; 171: 11-5.
33. Pastore S, Mascia F, Mariani V, Girolomoni G. Epidermal growth factor receptor ligands and tumor necrosis factor-alpha coregulate chemokine expression in human keratinocytes. Ann N Y Acad Sci 2002; 973: 210-3.
34. Mascia F, Mariani V, Girolomoni G, Pastore S. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 2003; 163: 303-12.
35. Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V, Girolomoni G. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 2005; 174: 5047-56.
36. Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996; 106: 446-53.
37. Pastore S, Fanales-Belasio E, Albanesi C, Chinni ML, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997; 99: 3009-17.
38. Pastore S, Giustizieri M, Mascia F, Giannetti A, Kaushansky K, Girolomoni G. Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. J Invest Dermatol 2000; 115: 1134-43.
39. Xing Z, Gauldie J, Tremblay GM, Hewlett BR, Addison C. Intradermal transgenic expression of granulocyte-macrophage colonystimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans cell/macrophage accumulation, and dermal fibrosis. Lab Invest 1997; 77: 615-22.
40. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-80.
41. Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R, et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003; 197: 1059-63.
42. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Cormeau MR, Campbell DJ, Ziegler SF. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 2005; 202: 541-9.
43. Kozma GT, Falus A, Bojszko A, Krikovszky D, Szabo T, Nagy A, Szalai C. Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1. Allergy 2002; 57: 160-3.
44. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004; 4: 978-88.
45. Yamazaki F, Aragane Y, Maeda A, Matsushita K, Ueno K, Yudate T, Kawada A, Tezuka T. Overactivation of IL-4-induced activator protein-1 in atopic dermatitis. J Dermatol Sci 2002; 28: 227-33.
46. Iversen L, Johansen C, Kragballe K. Signal transduction pathways in human epidermis. Eur J Dermatol 2005; 15: 4-12.
47. Jones MJ, Murray AW. Evidence that ceramide selectively inhibits protein kinase C-α translocation and modulates bradykinin activation of phospholipase D. J Biol Chem 1995; 270: 5007-13.
48. Nguyen C, Teo JL, Matsuda A, Eguchi M, Chi EY, Henderson Jr. WR, Kahn M. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci USA 2003; 100: 1169-73.
49. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-40.
50. Zeeuwen PLJM. Epidermal differentiation: the role of proteases and their inhibitors. Eur J Cell Biol 2004; 83: 761-73.
51. Magert H-J, Drögemüller K, Raghunath M. Serine proteinase inhibitors in the skin: role in homeostasis and disease. Curr Protein Pept Sci 2005; 6: 241-54
52. Ishibashi M, Arikawa J, Okamoto R, Kawashima M, Takagi Y, Ohguchi K, et al. Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. Lab Invest 2003; 83: 397-408.
53. Jensen J-M, Fölster-Holst R, Baranowsky A, Schunck M. Winoto-Morbach, Neuman C, Schütze S, Proksch E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2005; 122: 1423-31.
54. Hansson L, Backman A, Ny A, Edlund M, Ekholm E, Ekstrand Hammarstrom B, et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol 2002; 118: 444-9.
55. Vasilopoulos Y, Cork MJ, Murphy R, Williams HC, Robinson DA, Duff GW, et al. Genetic association between an AACC insertion in the 3′UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123: 62-6.
56. Hachem J-P, Man M-Q, Crumrine D, Uchida Y, Brown BE, Rogiers V, et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005; 125: 510-20.
57. Bitoun E, Chavanas S, Irvine AD, Lonie L, Bodemer C, Paradisi M, et al. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 2002; 118: 352-61.
58. Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, Ishida-Yamamoto A, et al. Spin/c5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005; 37: 56-65.
59. Ishida-Yamamoto A, Deraison C, Bonnart C, Bitoun E, Robinson R, O'Brien T, Wakamatsu K, et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol 2005; 124: 360-6.
60. Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, et al. Gene polymorphism in Netherton and common atopic disease. Nat Gen 2001; 29: 175-8.
61. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005; 26: 1-43.
62. Steinhoff M. Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M. Proteinase-activated receptor 2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003; 23: 6176-80.
63. Crivellato E, Ribatti D. Involvement of mast cells in angiogenesis and chronic inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 9-11.
64. Weidinger S, Rümmler L, Klopp N, Wagenpfeil S, Baurecht HJ, Fischer G, et al. Association study of mast cell chymase polymorphisms with atopy. Allergy 2005; 60: 1256-61.